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RESEARCH ARTICLE
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Abstract
Scabies is a skin infestation with the mite Sarcoptes scabiei causing itch and rash and is a
major risk factor for bacterial skin infections and severe complications. Here, we evaluated
the treatment outcome of 2866 asylum seekers who received (preventive) scabies treat-
ment before and during a scabies intervention programme (SIP) in the main reception centre
in the Netherlands between January 2014 and March 2016. A SIP was introduced in the
main national reception centre based on frequent observations of scabies and its complica-
tions amongst Eritrean and Ethiopian asylum seekers in the Netherlands. On arrival, all asy-
lum seekers from Eritrea or Ethiopia were checked for clinical scabies signs and received
ivermectin/permethrin either as prevention or treatment. A retrospective cohort study was
conducted to compare the reinfestations and complications of scabies in asylum seekers
who entered the Netherlands before and during the intervention and who received ivermec-
tin/permethrin. In total, 2866 asylum seekers received treatment during the study period
(January 2014 –March 2016) of which 1359 (47.4%) had clinical signs of scabies. During
the programme, most of the asylum seekers with scabies were already diagnosed on arrival
as part of the SIP screening (580 (64.7%) of the 897). Asylum seekers with more than one
scabies episode reduced from 42.0% (194/462) before the programme to 27.2% (243/897)
during the programme (RR = 0.64, 95% CI = 0.55–0.75). Development of scabies complica-
tions later in the asylum procedure reduced from 12.3% (57/462) to 4.6% (41/897). A sca-
bies prevention and treatment programme at start of the asylum procedure was feasible and
effective in the Netherlands; patients were diagnosed early and risk of reinfestations and







Citation: Beeres DT, Ravensbergen SJ, Heidema A,
Cornish D, Vonk M, Wijnholds LD, et al. (2018)
Efficacy of ivermectin mass-drug administration to
control scabies in asylum seekers in the
Netherlands: A retrospective cohort study between
January 2014 – March 2016. PLoS Negl Trop Dis
12(5): e0006401. https://doi.org/10.1371/journal.
pntd.0006401
Editor: Pamela L. C. Small, University of
Tennessee, UNITED STATES
Received: November 21, 2017
Accepted: March 22, 2018
Published: May 17, 2018
Copyright: © 2018 Beeres et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: Data are held upon
request considering the data are linked to a
vulnerable population. Data are available from the
UMCG Institutional Data Access for researchers
who meet the criteria for access to confidential
data. Please contact j.e.stavasius@umcg.nl (Joline
Stavasius, data management internal medicine/
UMCG).
complications reduced. To achieve a further decrease of scabies, implementation of the pro-
gramme in multiple asylum centres may be needed.
Author summary
The high number of asylum seekers arriving in Europe between 2014 and 2016 empha-
sized the importance to expand knowledge on best practice regarding health care provi-
sion and control of infectious diseases that may come with migration. Adequate control of
scabies is important to prevent severe forms of scabies and prevent spread of the disease.
Studies on interventions preventing or treating scabies in asylum seekers are very limited.
To the best of our knowledge, this is the first study that provides data on an intervention
targeting scabies in asylum seekers. This study shows that a scabies prevention and treat-
ment programme at start of the asylum procedure is feasible and effective in the Nether-
lands. Patients were diagnosed early and risk of reinfestations and complications reduced.
The programme may be used both to improve clinical practice and could serve as model
for future policies on similar programmes.
Introduction
In 2015, several outbreaks of scabies amongst asylum seekers at refugee camps and reception
centres in Europe were reported [1–3]. Scabies is an infestation of the skin with the mite Sar-
coptes scabiei. The mites are transmitted by close and prolonged skin to skin contact. Individu-
als with a severe form of scabies, such as crusted scabies, may harbour millions of mites and
are highly contagious [4]. A manifestation of scabies mostly results in skin burrows, erythema-
tous papules and generalized itching [5]. Secondary infections can lead to life-threatening
complications including sepsis [6]. In 2017, the WHO recognized scabies as a neglected tropi-
cal disease [7]. Crowded conditions and frequently poor access to health care are major risk
factors for scabies outbreaks and most likely gave rise to its recent emergence and spread in
refugee camps [8].
Individual patients with uncomplicated scabies can be efficiently treated with permethrin
or ivermectin [9]. However, mass outbreaks can be difficult to control and current knowledge
on adequate prevention and treatment strategies for scabies in asylum seekers is limited. On a
population level, mass drug administration with ivermectin was proven to be efficacious for
the control of scabies in a highly endemic population in Fiji [10]. The greatest decline in the
number of patients with scabies was seen in the treatment arm with 200ug/kg ivermectin [11].
Mass treatment with ivermectin and intensive active case finding results in long term control
of scabies in community settings, but previous studies have not dealt with outbreaks as seen in
asylum seekers [11,12].
In the Netherlands, the treating nurses and physicians noticed that asylum seekers originat-
ing from Eritrea and Ethiopia were particularly affected by scabies and frequently presented
complications related to scabies. For this reason, an intervention programme for scabies was
introduced in the national reception centres for asylum seekers in the Netherlands in July
2015.
This study aims to describe the epidemiology of scabies among asylum seekers that arrive
in the Netherlands and to evaluate the effectiveness of a scabies intervention programme (SIP).
We hypothesize that preventive treatment and early detection of scabies in a high-risk group
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reduces the number of episodes and the complication rate. Our data may conceivably help to
improve the care of asylum seekers with scabies and may be useful to implement screening
strategies in other vulnerable populations.
Methods
Ethics statement
This retrospective cohort study was evaluated by the ethics committee and was waived in
accordance with Dutch legislation owing to its retrospective nature (University Medical Centre
Groningen, METc number 2015/573). No written informed consent was obtained from
patients for the use of retrospective data but patient information was anonymized and de-iden-
tified prior to analysis.
Asylum seeking procedure in the Netherlands
The number of asylum seekers applications in the Netherlands was 29.790 in 2014, 56.370 in
2015, and 35100 in 2016 [13]. Among them, 13% (4056/29790) originated from Eritrea and
Ethiopia in 2014, 15.7% (8682/58880) in 2015, and 9.2% (3235/35100) in 2016 [13]. The Neth-
erlands operates a centralised system for asylum applications. Asylum seekers start their asy-
lum procedure at one of the three reception centres in the Netherlands; Ter Apel, Budel and
Veenhuizen. The majority of asylum seekers present at the reception centre in Ter Apel. Each
asylum seeker centre in the Netherlands has its own primary health care centre organised by
the national health care service for asylum seekers (GCA).
Within the first three days following arrival, individuals are identified, registered and then
screened for active pulmonary tuberculosis. The regional public health services and the pri-
mary health care centre of asylum seekers in Ter Apel started an entrant screening pro-
gramme, called the ‘Scabies Intervention Programme’ in July 2015 based on their observations
of complicated scabies amongst asylum seekers arriving from Ethiopia and Eritrea.
The scabies intervention programme
The SIP targeted asylum seekers from two countries. Asylum seekers from Eritrea and Ethio-
pia were selected based on the high prevalence of scabies observed among asylum seekers from
these countries. Only the asylum seekers from these two countries were actively screened and
were treated or given ivermectin/permethrin preventive treatment. It was practically not feasi-
ble to screen and treat all asylum seekers independent of their country of origin. In the first
two days after arrival all asylum seekers from Eritrea and Ethiopia received information about
scabies and its treatment with the help of a video in Tigrinya. Next their clothes were washed,
they received temporary clothes, and were examined by a nurse for skin lesions. The nurses
involved in the SIP worked at the health care centre which is based at the asylum centre. They
gained experience during the earlier scabies outbreaks. This experience was complemented by
training by the attending general practitioner based on a protocol developed by the National
Institute of Public Health and the Environment [14]. The protocol advices on standard exami-
nation of the limbs. If skin abnormalities were observed on these body parts, a full body exami-
nation was performed if approved by the asylum seeker. Hand lenses were available, but not
frequently used. During the intervention, the nurses would consult the attending physician if
in doubt and the physician could refer the patient to a dermatologist if needed.
Asylum seekers with skin lesions or complaints compatible with scabies were treated with
ivermectin at diagnosis and were invited to return to the health centre two weeks later in order
to receive a second dose of ivermectin. Asylum seekers with complicated scabies or other skin
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diseases were referred to the general practitioner at the primary health care centre Ter Apel for
immediate medical evaluation. All asylum seekers without a contraindication received iver-
mectin (0.2mg/kg, p.o.) under direct supervision of the nurse during the same visit. If ivermec-
tin was contraindicated, for example in pregnant women and in children under the age of one,
topical treatment with permethrin was given. All asylum seekers from Eritrea or Ethiopia with-
out clinical signs and symptoms of scabies received a single dose of ivermectin. They travelled
and arrived together and were considered to be contacts of the asylum seekers having scabies.
Selection of participants
A retrospective cohort study was conducted at the primary health care centre located in the
national reception centre for asylum seekers. The pharmacy records from the main reception
center Ter Apel were used to identify all asylum seekers who received ivermectin/permethrin
to treat or prevent scabies based on contact tracing between “January 1st 2014 and March 14th
2016. The medical records of these asylum seekers were followed over time (15–36 months) to
check for alternative diagnoses and repeated use of ivermectin/permethrin. Medical records of
asylum seekers are electronical patient files and can be accessed by health care workers in any
asylum centre in the Netherlands after transfer of the asylum seeker. Data from asylum seekers
were excluded from analysis if the pharmacy records in Ter Apel indicated use of ivermectin/
permethrin without any mentioning of these medications or the diagnosis scabies in the medi-
cal file. The extraction of the ivermectin/permethrin prescriptions from the pharmacy record
was independent of the country of origin of the asylum seeker. This data collection remained
the same before and after introduction of the SIP.
Data on demographic characteristics; comorbidities; clinical scabies manifestations includ-
ing complications; lab results (e.g. culture results from secondary infected lesions), and treat-
ment for scabies as given in the intervention programme and the standard care (ivermectin,
permethrin or both) have been extracted from medical records.
Scabies was defined as complicated if a patient had to be referred to the hospital, was treated
for secondary infections, needed wound care, or received antibiotics for scabies complications.
Rash and itch after scabies treatment may persist after successful treatment [15]. Complaints
or symptoms of scabies within two weeks of treatment were therefore counted as part of the
same episode.
Statistical analysis
IBM SPSS Statistics for Windows, Version 23.0 was used to collect and analyse the data.
Descriptive statistics were used for characteristics of all patients who visited the health care
centre and registered as having scabies. A Relative Risk (CI) was calculated for the reinfesta-
tions before and during the SIP. The number of days until first scabies manifestation before
and after the SIP was compared and calculated by Mann-Whitney-U.
Results
Study population and general characteristics
During the study period, 3201 asylum seekers received ivermectin/permethrin at least once.
Out of these asylum seekers, 2866 (89.5%) had a medical record with sufficient information to
be included for further analysis (Fig 1). Asylum seekers who needed scabies treatment or pro-
phylaxis before introduction of the SIP mainly originated from Ethiopia and Eritrea. The major-
ity was male, and the mean (sd) age was 24 (± 9) years. Comorbidities were reported among 32
asylum seekers before SIP, and among 49 asylum seekers after the SIP. Comorbidities included
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tuberculosis (n = 47), hepatitis B/C (n = 14), HIV (n = 14), and diabetes (n = 7). There was no
difference in the distribution of comorbidities before and after the SIP.
The indication for the use of ivermectin/permethrin in 2866 asylum seekers is summarized
in Table 1. During the SIP, 580 (64.7%) of the 897 asylum seekers with signs and symptoms of
scabies were identified through the scabies programme on arrival in the Netherlands and
received treatment at the reception centre on the first day of arrival. The other 317 (35.3%) asy-
lum seekers received their first treatment at one of the asylum health centres across the Nether-
lands after a median (IQR) of 83.5 days (46.8–178.8) after arrival.
Clinical manifestations and diagnosis of scabies
An overview of the clinical manifestations at the first episode of the 1359 scabies patients is
given in Table 2. 33.5% of the asylum seekers presented with more than one sign or symptom
of scabies. Itch was reported in 77% of the episodes. Other signs or symptoms include burrows
and other visible skin defects such as excoriations. Episodes with atypical presentations of sca-
bies in the face (n = 17) and neck (n = 13) were noticed in combination with lesions on the
hand and in the genital area (Fig 2).
Fig 1. Flow chart of study participants January 2014 –March 2016, IVM/PERM = ivermectin/permethrin.
https://doi.org/10.1371/journal.pntd.0006401.g001
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Of the 462 asylum seekers with signs and symptoms of scabies before start of the SIP,
12.3% presented with complications of scabies during their asylum procedure, compared to
4.6% of the 897 asylum seekers with signs of scabies after the start of the SIP (RR = 0.37, 95%
CI = 0.25–0.54). Asylum seekers with complications presented after a median (IQR) of 6.0
(1–28) days after arrival before start of the SIP and 0 (0–32) days during the SIP (U = 2863.5,
p = 0.005).











Before SIP (n = 532)
Male (%) 61.4 76.6 90.7 83.3 79.9
Country of
origin (n)
Eritrea 55 137 136 13 341
Ethiopia 13 95 44 4 156
Other Africa 0 14 2 1 17
Other; Eastern Europe &
South America
0 0 1 0 1
Other; Middle East &
South Asia
2 9 5 0 16
Missing 0 1 0 0 1
TOTAL 70 256 188 182 531
After initiation of the SIP (n = 2334)
Male (%) 54.3 75.9 81.1 65.8 62.3
Country of
origin (n)
Eritrea 644 183 67 128 1022
Ethiopia 745 260 91 135 1231
Other Africa 33 8 4 4 49
Other; Eastern Europe &
South America
5 1 1 1 8
Other; Middle East &
South Asia
10 9 4 1 24
TOTAL 1437 461 167 2692 2334
1Before the start of the SIP all preventive treatments were based on contact tracing. During the SIP contact tracing continued as part of standard care. All individuals
from Eritrea and Ethiopia without signs or symptoms of scabies received preventive treatment on arrival.
2Respectively 6 and 76 before and during SIP developed multiple scabies episodes despite preventive treatment. These patients are counted in this column only.
https://doi.org/10.1371/journal.pntd.0006401.t001







Clinical presentation n (%) n (%) n (%)
Itch 371 (80.3) 679 (75.7) 1050 (77.3)
Burrows 49 (10.6) 78 (8.7) 127 (9.3)
Other visible skin defects 161 (34.8) 282 (31.4) 443 (32.6)
Secondary infections 62 (13.4) 87 (9.7) 149 (11.0)
Crusted scabies 3 (0.006) 8 (0.009) 11 (0.009)
Missing in medical record 190 377 567
Complications related to scabies
Reported or diagnosed on arrival 17 (3.7) 62 (6.9) 79 (5.8)
Reported during asylum procedure 57 (12.3) 41 (4.6) 98 (7.2)
https://doi.org/10.1371/journal.pntd.0006401.t002
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None of the asylum seekers with skin problems interpreted as being scabies, proved to have
an alternative diagnosis during follow up. Before start of SIP, only 13 asylum seekers were ini-
tially misdiagnosed and were diagnosed with scabies at their second visit.
Treatment
As described in the previous section, 1359 scabies patients received treatment for the clinical
manifestations at the first disease episode. Ivermectin was given 1232 times and permethrin
was given 105 times. Twenty-two patients (not during the SIP) received a combined treatment
with ivermectin and permethrin due to the disease severity. The protocol included a second
dose of treatment after two weeks for the asylum seekers that presented with clinical signs and
symptoms of scabies. Among them, 34% (461/1359) had a notification of the intake of a second
dose of treatment in their medical record. Scabies reinfestations were more common among
individuals reporting the intake of a single dose of ivermectin 40.0% (286/717) compared to
the individuals that report the intake of a second dose of ivermectin 27.3% (175/642) (RR =
1.37 95% CI (1.20–1.57).
Antibiotics were prescribed in 117 (68.5%) of the 149 asylum seekers with secondary infec-
tions. Most frequently prescribed antibiotics were flucloxacillin (55), amoxicillin/clavulanic
acid (29), and fusidic acid (29). Incision and drainage of abscesses were performed in 35
patients. Wound care was needed in 85 patients. Cultures were performed in 12 asylum seekers
Fig 2. Density map of the distribution of scabies signs and symptoms at different body parts. locations of scabies
signs were missing in medical record for 386 patients.
https://doi.org/10.1371/journal.pntd.0006401.g002
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with secondary infections at the health care centre of the national reception centre. Cultures
showed Methicillin-Sensitive Staphylococcus aureus (MSSA) in 9 patients and Methicillin-
Resistant Staphylococcus aureus (MRSA) in 3 patients.
Reinfestations
Reinfestations were more common amongst scabies patients before introduction of SIP. Dur-
ing the SIP, 27.2% (243/897) of the scabies patients had more than one disease episode versus
44% (194/462) of the scabies patients before start of the SIP (RR = 0.64, 95% CI = 0.55–0.75).
In total 1691 asylum seekers received preventive treatment on arrival, of which 269 (15.9%)
asylum seekers were diagnosed with scabies later in their asylum procedure (after a median
(IQR) days of 75 (44–146)). The majority (242 of the 269 (90.0%)) reported during their stay
in asylum health centres other than the national receptions centres Ter Apel and Budel. There
was no proactive scabies programme in these asylum centres.
Discussion
Frequent observations of scabies and its complications were reported amongst Eritrean and
Ethiopian asylum seekers arriving in the Netherlands. Introduction of a scabies prevention
and treatment programme on arrival was feasible and resulted in early detection of asylum
seekers with scabies. Itch and burrows were the most common clinical manifestations. Atypi-
cal scabies presentations in the face and neck were also noticed. The number of scabies reinfes-
tations after treatment and the number of complicated forms of scabies reduced after
introduction of the programme. Asylum seekers who received ivermectin/permethrin on
arrival but developed scabies in other asylum centres across the Netherlands, presented after a
median of 2.5 months after arrival.
Introduction of the SIP was effective in the prevention of scabies outbreaks. Given the high
number of the asylum applications in 2014 and 2015 [13] a target group for the intervention
was selected. The few scabies manifestations amongst asylum seekers from countries other
than Ethiopia and Eritrea suggests that the target group of the SIP was well chosen.
Reinfestations after scabies treatment were common before the programme started. After
introduction, the number of scabies episodes per person reduced significantly. Prompt treat-
ment of new cases is important for successful scabies control in institutional settings [16,17].
In other institutional settings, a public jail and a hospital ward, collective treatment of persons
with oral ivermectin in both a treatment and prophylaxis setting appeared to be effective in the
treatment of scabies [18,19]. In our study, newly developed scabies episodes were mainly seen
in asylum health centres other than the national reception centres Ter Apel and Budel. These
centres did not have a scabies prevention and treatment programme. This indicates that to
achieve a further decrease of scabies, implementation of the programme in multiple asylum
centres may be needed.
Definitive diagnosis of scabies relies on microscopic identification of the mites or eggs [20].
However, scabies diagnosis based on clinical recognition by well-trained nurses seemed effi-
cient in this setting with high pre-test probability of having scabies if asylum seekers had itch-
ing or typical skin lesion; no scabies patients received alternative diagnoses during follow-up.
Diagnostic accuracy of scabies diagnosis based on the combination of symptoms and signs rec-
ognition was also proven in a study performed in Mali and Senegal [21]. Over diagnosis of sca-
bies during the SIP could be a factor that contributed to the reduced reinfestations since start
of the SIP, but the data collected in this setting with a high pre-test probability of scabies sug-
gests a good positive predictive value.
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Secondary infections and complications are common amongst scabies patients [22]. Intro-
duction of the programme reduced the number and the severity of the complicated forms of
scabies. It has been suggested that scabies mites provide favourable conditions for onset of S.
aureus co-infection [23]. Severe forms of scabies such as bacterial super infections and crusted
scabies were reported in this study. Culture of the secondary infections tested positive for both
the presence of MSSA and MRSA. However, the number of coinfections is relatively low com-
pared to other studies that describe secondary infections related to scabies [24].
A limitation of this study is the unknown duration of stay of the asylum seekers in the asy-
lum centers. Therefore, it is impossible to calculate the exact incidence rate of scabies. Due to
the frequent relocations of asylum seekers to other asylum centers within the Netherlands
without a proactive scabies programme, reinfestations may occur by contact with untreated
contagious individuals. Scabies manifestations after preventive treatment occurred after a min-
imum time period of two and a half months, suggesting that initial preventive treatment was
effective. Other factors may have led to a reduction in the rate of reinfestations which are not
included in this study, e.g. improved housing of asylum seekers. However, we are unaware of
such changes in policy that could lead to a reduction in the rate of reinfestations.
Finally, participation in the SIP was on a voluntary basis. The number of patients that
refused participation in the programme is unknown and these individuals could influence the
efficacy of the programme. However, health care workers did not observe asylum seekers who
refused participation which suggests that refusal rate was low.
Controlling scabies amongst asylum seekers is important to reduce the risk of complicated
cases and to prevent the spread of scabies amongst asylum seekers at asylum centres in the
Netherlands. The centralized health care system for asylum seekers that is used in the Nether-
lands allows accurate follow up of asylum seekers and provides unique retrospective data on
the programme.
The systematic examination of the skin by nurses as part of this programme also results in
early identification of other skin diseases such as chronic wounds, cutaneous leishmaniasis and
eczema and leads to referral to the general practitioner in case of other systemic signs like fever.
This programme therefore has the potential for an integrated control of skin conditions and
human-to-human transmittable diseases, such as louse borne relapsing fever [25]. To our knowl-
edge this is the first study to investigate the effect of a screening and mass-drug administration
programme for scabies control in asylum seekers. The programme helped to be up to scratch with
itchy outbreaks by early detection and reducing the number of reinfestations and complications.
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